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Cell differentiation entails early lineage choices leading to the activation, and the subsequentmaintenance, of
the gene expression program characteristic of each cell type. Alternative lineage choices involve the activa-
tion of different regulatory and coding regions of the genome, a process instructed by lineage-determining
transcription factors, and at least in part mediated by the deposition of chromatinmarks thatmodify function-
ality and accessibility of the underlying genome. According to classic epigenetics, subsequent maintenance
of chromatinmarks acrossmitoses and in spite of environmental perturbations occurs largely through auton-
omous and unsupervised mechanisms. However, paradigmatic genetic and biochemical studies in immune
system and hematopoietic cells strongly point to the concept that both induction and maintenance of the
differentiated state require constant supervision by lineage-determining transcription factors, which may
act to globally organize the genome in both the one- and the three-dimensional space.Introduction
The concept that there is no loss of geneticmaterial during differ-
entiation in complex multicellular organisms and therefore that
the DNA content of somatic cells is sufficient to program the
formation of a complete organism was definitively established
by the landmark nuclear transplantation experiments of Laskey
and Gurdon in 1970 (Laskey and Gurdon, 1970). These experi-
ments provided evidence that cell differentiation is the conse-
quence of mechanisms that restrict the usage of large genomes
and maintain cell type-specific gene expression programs.
Before such experiments, however, the concept that the same
genotype can give rise to different phenotypes was already
well established in the scientific community: this concept is at
the heart of epigenetics, which is traditionally defined as ‘‘the
study of mitotically and/or meiotically heritable changes in
gene function that cannot be explained by changes in DNA
sequence’’ (Russo et al., 1996). Heritability of gene activity
across mitosis is the essence of this definition as well as of
classic epigenetics, implying that once established, the state
of gene activity can be transmitted to daughter cells autono-
mously and without supervision (Bird, 2007). This simple and
fascinating idea, that genes retain a memory of their functional
state, has been translated into precise molecular mechanisms
after the realization that chromatin is a moldable template
subject to modifications that alter the accessibility and function
of the underlying genetic material (Jenuwein and Allis, 2001).
Some of these modifications, like DNA methylation, are trans-
mitted to the newly synthesized chromatin fiber, thereby
accounting for memory of the functional state (Russo et al.,
1996). The complement of all chromatin modifications applied
to the genome, and that is specific to every given cell type, is
commonly referred to as the epigenome (Bernstein et al.,
2007). Cell type-specific differences in the epigenome reflect
alternative ways in which the available genetic information is in-
dexed, causing some portions of the genome to remain acces-
sible and others to be sequestered into inactive domains, that12 Immunity 33, July 23, 2010 ª2010 Elsevier Inc.in some cases are compacted to generate cytologically identifi-
able heterochromatin.
What has become clear in recent years, however, is that chro-
matin modifications are highly dynamic, as shown by the fact
that they reflect the continuous antagonistic activity of enzymes
that catalyze their deposition and removal: for instance, the half
life of the acetyl group on histones at gene promoters is in the
order of minutes (Hazzalin and Mahadevan, 2005). These tran-
sient modifications, which either represent a bystander effect
or are the determinants of a given functional state, are unlikely
to be propagated across mitosis. Formally, these dynamic chro-
matin alterations linked to transient changes in gene activity,
which are commonly found in cells exposed to environmental
stimuli (Smale, 2010), are not considered epigenetic phe-
nomena. Nevertheless, mechanisms and molecules involved in
canonical epigenetic phenomena and in dynamic chromatin
modifications extensively overlap. Moreover, the formal demon-
stration that chromatin modifications can be autonomously
transmitted across mitosis is not as simple as it may seem,
because it requires the complete abrogation of the original
signal(s) and mediator(s) that led to establishment of such chro-
matin states in the mother cell. Therefore, epigenetics more
commonly refers to all events in which chromatin modifications
impart functional changes in gene activity, irrespective of their
heritability. In this prevailing usage, an epigenetic event can be
defined as ‘‘the structural adaptation (or modification) of chro-
mosomal regions so as to register, signal, or perpetuate altered
activity states’’ (Bird, 2007). This definition implies (1) that epige-
netic events are adaptive or responsive, namely that they are
originally instructed by specific factors (particularly transcription
factors), even though their subsequent maintenance may occur
autonomously; (2) that the modifications possess information
content and thus directly contribute to regulation of chromo-
some and gene function (although they may in some conditions
represent bystander effects and be without functional rele-
vance); (3) and that the epigenetic event in some cases may be
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within a single generation), but in other cases it controls only
transient functional changes.
Detailed studies on lineage determination and maintenance in
the immune system provide paradigms, potentially exportable to
other systems, which may refine or refocus classic concepts in
epigenetic control.
In this review I will analyze some aspects of epigenetic regula-
tion via selected examples coming from studies in immune
system cells. Based on recent data, I will develop a model
explaining how fate-determining transcription factors may work
to globally organize and maintain lineage-specific epigenomes.
Functional Annotation of Mammalian Genomes
via Histone Modifications
Chromatin organization has been the focus of many excellent
reviews in recent years (Bernstein et al., 2007; Campos and
Reinberg, 2009; Fraser and Bickmore, 2007; Kouzarides, 2007;
Misteli, 2007). Therefore, I will only briefly discuss a few basic
concepts that are directly relevant to the topic of this review.
Covalent modifications (acetylation, methylation, phosphory-
lation, and others) of the amino termini of nucleosomal histones
(histone tails) specifically correlate with distinct functional states
(Kouzarides, 2007). Therefore, independently of the causative
role of histone tail modifications, their distribution along the
genome is a sensitive and specific indicator of the functionality
of the underlying genomic regions (Bernstein et al., 2007).
Progress in this area has been fostered by technological innova-
tion and particularly by the combination of chromatin immuno-
precipitation (using antibodies for modified histones) and high-
throughput detection technologies like tiling microarrays (Ren
et al., 2000) and, more recently, multiparallel sequencing (ChIP-
sequencing or ChIP-Seq) (Barski et al., 2007; Johnson et al.,
2007; Robertson et al., 2007). For instance, the trimethylation
of lysine 4 in histone H3 (H3K4me3) is specifically associated
with a few nucleosomes placed just downstream of the tran-
scription start sites (TSS) of active or poised genes (Kim et al.,
2005; Bernstein et al., 2006; Roh et al., 2006), and its levels
tend to correlate with transcription rates (although H3K4me3
usually persists long after transcription has been shut off) (Ng
et al., 2003). H3K36me2 (or H3K36me3) and H3K79me2 are
specifically associated with actively transcribed coding units
throughout their length (Mikkelsen et al., 2007). This combination
of H3K4me3 and H3K36me2 provides a chromatin signature that
specifically defines the boundaries of active transcription units.
Conversely, H3K27me3 and H3K9me3 are associated with
stably silenced regions, including repeats (Bernstein et al.,
2007; Martens et al., 2005), and unlike H3K4me3 they tend to
form large blocks, particularly in differentiated cells (Pauler
et al., 2009; Wen et al., 2009).
Irrespective of their location relative to coding units, transcrip-
tional enhancers are defined by a simple but apparently specific
chromatin signature that consists of high amounts of H3K4me1
and low or undetectable H3K4me3 (H3K4me1hi/H3K4me3lo
domains) (Heintzman et al., 2007, 2009). In partial conflict with
this notion is the observation that a subset of intergenic regions
considered as putative enhancers based on their DNase hyper-
sensitivity (see below) and their location outside of mapped
protein coding genes were shown to possess high amounts ofH3K4me3 (Wang et al., 2008). However, it is likely that these
regions may represent bona fide noncoding RNA genes rather
than enhancers (De Santa et al., 2010). Histone tail methylation
associated with actively transcribed regions (but not with
enhancers) depends on multimolecular enzymatic complexes
that are recruited by virtue of their association with the car-
boxy-terminal repeat domain (CTD) of the large subunit of RNA
polymerase II (Pol II) (Shilatifard, 2006). Therefore, the deposition
of these histone marks must be seen as a cotranscriptional
event. In other cases, like H3K27me3 and H3K9me3, sequence-
specific transcription factors (TFs) are directly responsible for
recruiting the enzymes that catalyze the modification (Schuet-
tengruber et al., 2007).
The analysis of the genomic distribution of histone modifica-
tions (epigenomes) in different cell types has provided a direct
molecular counterpart to the concept that different cells use
alternative and distinct fractions of genomic information. For
instance, the genomic regions with a chromatin signature of
enhancers seem to show little overlap across different continu-
ously cultured cell lines (Heintzmann et al., 2009), suggesting
that a sizeable fraction of the enhancer repertoire may be cell
type specific: of all the possible regulatory regions in the
genome, only a small, specific subset is selected for activation
in every cell type, which is probably essential for cell differentia-
tion. It is similarly likely that primary or secondary alterations
in the way such regulatory repertoire is used may underlie
many diseases characterized by a perturbation of differentiation
(including cancer). The recognition that chromatin marks provide
a direct readout for the differential usage (in physiology or in
disease) of genomic information is the rationale for large interna-
tional efforts (like the International Human Epigenome Consor-
tium, IHEC) that aim at generating a comprehensive catalog of
epigenomes in normal and pathological cells, and thus strive
to determine the deepest roots of gene expression changes
in health and disease (http://www.nature.com/news/2010/
100203/full/463596b.html).
The Making of an Epigenome: General Principles
As discussed above, the chromatinized genome can be seen as
a template that can be flexibly modified in response to fate-
determining and lineage-specific TFs to acquire properties char-
acteristic of a given cell type. At the same time, the epigenome is
constantly influenced by signals received from themicroenviron-
ment. Such signals, depending on their nature and origin, will
cause either transient changes in gene activity and the deposi-
tion of chromatin marks that will not be transmitted to the cell
progeny, or persistent chromatin alterations that will provoke
long-lasting effects on parenchymal and stromal cells. Overall,
the epigenome of a given cell at a specific time must reflect
the developmental history of the cell and more or less recent
environmental signals. An extreme example of how the environ-
ment impacts on the epigenome is provided by the changes in
DNA methylation brought about by variations in the dietary
income of folic acid in mice (Waterland and Jirtle, 2003). Even
more strikingly, patients with terminal kidney disease accumu-
late S-adenosylhomocysteine, which acts as a competitive
inhibitor of S-adenosylmethionine, the universal donor of methyl
groups. As a consequence, these patients develop a global DNA
hypomethylation and express imprinted alleles (that are normallyImmunity 33, July 23, 2010 ª2010 Elsevier Inc. 13
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Figure 1. Cell Type-Specific Epigenomes
A schematic genomic region containing three
genes (A, B, and C) and intergenic regulatory
regions (in purple) is shown in the middle. Arrows
indicate the transcription start sites. In the upper
part, the H3K4me1 profiles found in two different
cell types are depicted. These profiles indicate
that the regulatory regions functional as enhancers
in the two cell types are different. In the bottom
part, H3K4me3 association is shown to identify
the TSSs of active genes. Although the H3K4me3
profiles at a given gene (e.g., gene B) in different
cell types may be very similar or apparently iden-
tical, base pair-level analysis of transcription initia-
tion sites indicates that the precise location of the
TSS may be shifted in distinct cell types, which
suggests the role of cell type-specific signals in
fine-scale TSS selection.
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ment with folic acid, which reduces S-adenosylhomocysteine
in the blood, restores normal DNA methylation levels and
imprinting (Ingrosso et al., 2003).
For cells of the immune system, and particularly for those of
the innate immune system, whose role is primarily to scan
tissues for presence of microbial and nonmicrobial danger
signals, environmental factors may have widespread effects on
the epigenome. For instance, hundreds of new H3K4me3 peaks
appear after a few hours from endotoxin stimulation of macro-
phages (De Santa et al., 2009; Foster et al., 2007). These peaks
tend to persist after the initial transcriptional wave is exhausted
and this correlates with a faster reactivation of some of the asso-
ciated genes at restimulation (Foster et al., 2007). Because of the
reactive nature of some chromatin modifications, dedicated and
specific mechanisms must be deployed in order to prevent a
progressive alteration of the epigenome resulting from exposure
to environmental inputs (see below).
Two essential components of the epigenome are enhancers
and TSSs, which are both, to a different extent, cell type specific
(Figure 1).
The Making of the Enhancer Repertoire
Spotting enhancers in the large genomes of higher eukaryotes
has always been challenging. At individual genomic loci, regula-
tory elements have been traditionally identified on the basis of
their increased accessibility to exogenous nucleases (Wu,
1980). However, until recently this approach could not be scaled
up to a genome-wide level (Boyle et al., 2008; Gargiulo et al.,
2009), and systematic identification of enhancers almost exclu-
sively relied on detection of sequences (in introns or intergenic
regions) that are conserved across multiple species (Boffelli
et al., 2003; Prabhakar et al., 2006). However, this approach14 Immunity 33, July 23, 2010 ª2010 Elsevier Inc.has two main limitations: first, sequence
conservation does not provide any infor-
mation on the tissue(s) where that
enhancer is active. Second, it overlooks
species-specific enhancers or enhancers
whose sequence evolved rapidly. This is
a problem particularly for enhancers that
control genes involved in environmental
responses, like the response to microbesand environmental toxins. Environmental response genes (and
presumably also their regulatory regions) show high rates of
duplications and losses during evolution, which is a reflection
of the differences in the environment to which different species
are exposed (Ponting, 2008). For these reasons, the identifica-
tion of a simple but specific enhancer-associated chromatin
signature was a major breakthrough in the field (Heintzmann
et al., 2007). This signature consists of high amounts of
H3K4me1 combined with low H3K4me3 and usually extends
over hundreds or a few thousands nucleotides. Enhancers also
show histone acetylation (particularly H3K27Ac) and are bound
by histone acetyltransferases at a single, discrete central site
that usually corresponds to the region of highest sequence
conservation and contains TF binding sites (and can therefore
be considered the functional core). Combinatorial histone modi-
fications at enhancers may in fact be more complicated (Wang
et al., 2008), but the H3K4me1/H3K4me3 signature nevertheless
provides a useful and simple tool to identify putative regulatory
regions. Although some enhancers are transcribed by RNA
Polymerase II, thus generating noncoding RNAs (Kim et al.,
2010; De Santa et al., 2010), this is a rather uncommon occur-
rence. Lack of transcription at most enhancers implies that the
H3K4me1 found at enhancers is not a cotranscriptional mark in
the vast majority of cases, and suggests that the responsible
methyl-transferases (that are still unknown) must be recruited
in alternative manners, probably by association with sequence-
specific TFs. Most importantly, enhancers are at least to a large
extent cell type specific (Heintzman et al., 2009; Heinz et al.,
2010), meaning that the genomic regions that are used as
enhancers are different in different cell types (Figure 1). This
implies that cell type-specific signals must be involved in
the activation of discrete genomic regions as enhancers. From
this point of view, the genomes of higher eukaryotes can be
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Naive genome
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1-D
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Figure 2. From One Genome to Many Epigenomes
A schematic genomic region is shown, with all potential regulatory regions
indicated by arrows. These regions must be functionalized by binding of
lineage-determining TFs that possess distinct DNA-binding specificities and
therefore different genomic distributions. The linear (1D) epigenomes (for
instance the linear distribution of enhancers along the genome) are in vitro
representations: in vivo, the genome is highly folded in the 3D space in
a manner that may reflect cell type-specific cues, thus generating alternative
‘‘3D epigenomes.’’
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that are differentially activated in different cell types. As I will
discuss below, recent experimental data support the notion
that TFs involved in lineage commitment and maintenance of
cell identity (heretofore indicated as commitment and identity
factors) are directly responsible for activation as enhancers of
the genomic regions they bind (Figure 2).
Enhancer Marking in ES Cells
The process leading to formation of tissue-specific enhancers
probably starts at the earliest phases of embryonic development.
In ES cells, some genomic regions destined to become tissue-
specific enhancers are bound by pioneer TFs expressed by
pluripotent cells, leading to the creation of small windows of un-
methylated CpGs surrounded by methylated DNA (Xu et al.,
2007, 2009). These unmethylated windows can be considered
poised core enhancers whose fate will depend on subsequent
differentiation events. Tissue-specific enhancers will in most
cases be remethylated upon differentiation toward lineages in
which they are inactive, and conversely kept unmethylated in
tissues where they are functional. Maintenance of the demethy-
lated window may in this case require the replacement of the
pioneer TF expressed in ES cells with a lineage-restricted TF.
For instance, FoxA1 replaces the ES cell Foxd3 at the liver-
specific Alb1 enhancerwhen ES cells differentiate into endoderm(Xu et al., 2009). Remethylation of enhancers during differentia-
tion toward alternative lineages extinguishes their activity and
this may represent an efficient barrier against the reactivation of
these enhancers. The effects of a reduction in Dnmt1 levels
upon hematopoietic stem cell (HSC) differentiation exemplify
how DNA methylation impacts lineage choices. HSCs with
reduced Dnmt1 expression were unable to suppress the myelo-
erithroid gene expression program and therefore to differentiate
toward the lymphoid lineage (Bro¨ske et al., 2009). Although the
precise molecular defect underlying this phenotype is unknown,
a defective inactivation (via methylation) of enhancers controlling
myelo-erythroid differentiation is a likely explanation.
However, in some cases the DNA methylation barrier can be
overcome and methylated enhancers can be reactivated. This
was shown for instance at the regulatory regions controlling
the immunoglobulin k chain gene in B lymphocytes, whose reac-
tivation can be driven by the NF-kB protein RelB (Kirillov et al.,
1996).
Enhancer Activation by Lineage-Determining TFs
The second step in enhancer marking and activation is repre-
sented by the binding of TFs expressed in the differentiated
tissue in which a given enhancer is active, which transforms
potential regulatory modules into transcriptionally competent
regulatory elements. This marking may occur at an early step
in lineage commitment and precede transcriptional activation.
Lineage-commitment and identity factors are logical candidates
for enhancer marking. In a reciprocal fashion, it can be safely
claimed that an essential component of the instructive role of
TFs in lineage determination is the creation of a cell type-specific
repertoire of active enhancers (Figure 2).
Some examples in the hematopoietic and immune system
strongly support this notion. I will start from a paradigmatic
pair of lineage-determining TFs that antagonistically control
erythroid-megakaryocytic and myeloid development, respec-
tively: GATA-1 and PU.1 (Graf and Enver, 2009). Upon ectopic
expression, GATA-1 was shown to cause macrophage precur-
sors to express megakaryocyte and erythroid markers and to
downregulate or completely switch off PU.1-dependent myeloid
markers (Kulessa et al., 1995; Visvader et al., 1992). The recip-
rocal experiment led to the reciprocal outcome: enforced
expression of PU.1 in an erythroid-megakaryocytic cell line con-
verted it intomyeloid cells similar tomacrophages, which lost the
expression of GATA-1-regulated erythroid and megakaryocytic
genes (Nerlov and Graf, 1998).
Data on the genomic distribution of GATA-1 (Fujiwara et al.,
2009; Yu et al., 2009; Cheng et al., 2009) and PU.1 (Ghisletti
et al., 2010; Heinz et al., 2010) provided important clues on the
underlying mechanisms. In mouse erythroblasts, GATA-1 marks
about 15,000 genomic sites, including TSSs and regions located
distally to promoters, including already identified enhancers
active in erythroid cells (Cheng et al., 2009). In principle, it is pos-
sible that such a large number of sites may reflect nonfunctional
binding events resulting from randomly occurring sequences of
nucleotides that resemble or match the specific GATA-1 binding
sites. Moreover, every TF has an intrinsic affinity for DNA (irre-
spective of its sequence) that, although orders of magnitudes
lower than the affinity for specific sites, may account for nonspe-
cific binding events detected by ChIP-Seq. However, the factImmunity 33, July 23, 2010 ª2010 Elsevier Inc. 15
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associated with the chromatin signature of enhancers (Cheng
et al., 2009) makes this scenario rather unlikely and conversely
suggests that binding to most genomic regions reflects specific
regulatory events. Similarly, in mouse macrophages PU.1 marks
about 45,000 genomic regions (Ghisletti et al., 2010). 80% of
them were located distally from mapped TSSs and also in this
case associated with the canonical chromatin signature of
enhancers. Importantly, when we compared the GATA1 ChIP-
Seq data set (Cheng et al., 2009) with the PU.1 data set, only
a small fraction (3.5%) of the bound genomic regions overlapped
(our unpublished data). Therefore, the ability of GATA-1 and PU.1
to drive alternative gene expression and differentiation programs
correlates with the marking of a largely different set of genomic
regulatory regions.
Some additional data on PU.1 are worth mentioning. First, it
appears that virtually no H3K4me1hi/H3K4me3lo region is devoid
of PU.1 binding in macrophages (Ghisletti et al., 2010). Although
the possibility exists that some enhancers may be associated
with a completely different and yet unknownchromatin signature,
this result suggests that the association of PU.1with enhancers is
systematic. In otherwords, nearly thewhole complement of regu-
latory regions inmacrophages appears tobeboundbyPU.1. This
may not be the case for GATA-1; its genomic distribution seems
to bemore restricted (15,000 versus 45,000 sites; however, these
differences may have a trivial explanation, namely a lower effi-
ciency of the GATA-1 ChIP as compared to the PU.1 ChIP).
Second, ectopic expression of PU.1 in fibroblasts, which induces
their partial conversion into macrophage-like cells (Feng et al.,
2008), was sufficient to induce nucleosome remodeling and
H3K4me1 deposition at the same genomic locations found in
macrophages (Ghisletti et al., 2010; our unpublished data).
In a similar experiment, reconstitution of PU.1 expression in
PU.1-deficientmyeloid progenitors led to sequential nucleosome
remodeling and increased H3K4me1 levels at PU.1 binding sites
(Heinz et al., 2010). Moreover, PU.1 depletion resulted in the
reduction of H3K4me1 amounts at several tested enhancers
(Ghisletti et al., 2010). The fact that PU.1 binding is sufficient
and required to change the modification state of the neighboring
chromatin strongly argues against the possibility that themajority
of binding events are nonfunctional and conversely implies
a widespread role of this (and possibly many others) lineage-
determining TFs in actively shaping the epigenome.
These observations suggest that at least in some cases the
main role of lineage-commitment and identity factors like PU.1
and GATA-1 may be far more complex than the mere and exclu-
sive induction of genes critical for a specific lineage (e.g., M-CSF
receptor for macrophages). Conversely, they may exert a perva-
sive role in controlling the whole repertoire of regulatory genomic
regions active in a given lineage. In keeping with this notion, cell
type-specific promoter-distal regionsmarked byH3K4me1 in ES
cell, T lymphocytes, and erythrocyte precursors are enriched in
binding sites for TFs required for lineage commitment and main-
tenance of the respective cell identity (Heinz et al., 2010) (see
below).
Cell Type Specificity in Promoter Selection
Promoters (and associated TSSs) can be identified by specific
chromatin marks, most notably H3K4me3 (Bernstein et al.,16 Immunity 33, July 23, 2010 ª2010 Elsevier Inc.2007). On a genome-wide scale, and judging from the H3K4me3
mark, promoters seem to be more similar across cell types than
enhancers (Heintzman et al., 2009). However, this observation
must be taken cautiously, because it reflects the prevalence
in the genome of CpG island-containing promoters (including
housekeeping genes and tissue-specific genes with a CpG
island) (Ramirez-Carrozzi et al., 2009), which are constitutively
methylated at H3K4me3 (see below). Moreover, this observation
does not imply at all that chromatin marks at promoters are not
under active and dynamic control. In fact, H3K4me3 is a highly
reactive modification that is completely absent from the TSSs
of inactive genes lacking a CpG island, and is strongly upregu-
lated upon activation, as shown at many inducible genes in
macrophages (De Santa et al., 2009; Foster et al., 2007;
Hargreaves et al., 2009; Ramirez-Carrozzi et al., 2009). More
importantly, the homogeneity across cell types of H3K4me3
profiles at TSSs and promoters of CpG island-containing genes
does not necessarily argue against the notion that also TSSsmay
be subjected to regulation by cell type-specific cues. The most
widely known situation is that of alternative promoter (and
TSS) usage in different cell types. One classical example in the
immune system is the expression of the class II transactivator
(CIITA), a TF controlling MHC class II genes. CIITA expression
is under the control of different promoters in B lymphocytes
and dendritic cells (Muhlethaler-Mottet et al., 1997), which
establish TSSs spaced several kilobases from each other.
High-throughput techniques for the base pair level mapping of
TSSs have suggested the intriguing possibility that tissue-
specific cues may also lead to a fine-scale regulation of TSS
selection. Large-scale analysis of TSSs in multiple tissues
revealed two main patterns (Carninci et al., 2006; Kawaji et al.,
2006). On the one hand, TATA box-containing promoters were
generally associated with a single dominant TSS in all tissues.
On the other, most of the remaining promoters, and particularly
those associated with CpG islands (including many house-
keeping genes), showed broad (150–200 bp) regions of tran-
scription initiation, in which one or a few dominant TSS(s) could
be identified, which differed among tissues (Figure 1). These data
are compatible with two possibilities. First, lack of strong core
promoter elements like the TATA boxmay imply that these genes
do not require a precise definition of their TSS. Therefore,
depending on the relative concentrations of components of the
general transcriptional machinery in different cell types, different
initiation sites may be preferentially used (being differences
among cell types devoid of regulatory consequences). Alterna-
tively, tissue specificity may indicate that these broad transcrip-
tion initiation regions do not reflect a noisy behavior and an
intrinsic infidelity of the transcriptional machinery, but conversely
the effect of tissue-restricted signals that affect TSS selection
at the base pair level. In this scenario, lack of a strong core
promoter element (like a TATA box) may be permissive for
such plasticity in TSS selection; in turn, cell type specificity in
TSS selection may have an impact on the usage of promoter
elements, thus bringing about transcriptional changes. In this
light, it is intriguing that factors like PU.1 and GATA-1 extensively
mark active TSSs (Cheng et al., 2009; Fujiwara et al., 2009;
Ghisletti et al., 2010; Yu et al., 2009). Therefore, marking of tran-
scriptional regulatory regions by PU.1 is not limited to almost the
totality of identifiable enhancers, but also extends to the majority
Immunity
Reviewof active TSSs and promoters, including those of non-tissue-
specific and housekeeping genes. This scenario may simply
reflect a general affinity of TFs like PU.1 and GATA-1 toward
active TSSs and it need not reflect functionality. Alternatively,
PU.1 and GATA-1 may directly control fine-scale TSS selection,
which would help explain the cell type specificity in TSS location
described above. Somedata that strongly support this possibility
have been reported. In PU.1-negative myeloid cells, re-expres-
sion of PU.1 is sufficient to shift the position of the major TSS of
the mouse Tlr4 gene by about 200 bp, to a position just down-
stream of a PU.1 site (Lichtinger et al., 2007). Moreover, at the
gene that encodes defensin-1, a PU.1 site adjacent to a TTTAAA
element (which may represent a weak TATA box) is required to
recruit the transcriptional machinery; however, if the TTTAAA
element is replaced by a canonical TATA box, the PU.1 site is
no longer required for gene activation, suggesting that PU.1 is
essential to recruit and position the transcriptional machinery in
the absence of a strong core promoter (Yaneva et al., 2006).
More in general, the promoters of many macrophage-specific
genes do not contain canonical core promoter elements (like
a TATA box or the Inr) (Hume et al., 2008); conversely, they
contain clusters of PU.1 sites, the last one of such sites being
often located just upstream of the mapped TSS (Tenen et al.,
1997). Overall, these data suggest that in the absence of strong
core promoter elements, PU.1 may directly control the site of
transcriptional initiation. Whether this holds true also for other
lineage-restricted TFs, however, remains to be determined.
With all the due caution in this regard, the intriguing scenario
suggested by these data is that transcription initiation may be
carefully supervised and finely tuned by cell type-specific
signals. This is somehow against the standard notions and
should urge a rethinking of how cells exert a global control
over transcriptional events. Overall, lineage commitment and
identity factors like PU.1 and GATA-1 may be able to supervise
in a very pervasive, systematic manner, nearly all of genomic
regions controlling transcriptional regulation. The potential impli-
cations of these observations will be discussed below.
Maintaining DNA Methylation Patterns
Once the epigenome characteristic of a given cell type is estab-
lished, its maintenance faces two main challenges: DNA replica-
tion (leading to the synthesis of new chromatin fibers where the
distribution of modifications of the parental fibers must be faith-
fully reproduced) and environmental stimuli (which induce chro-
matin changes that can alter the epigenome). It is predictable
that the relative disruptive potential of mitosis and external
stimuli will be different depending on the properties (proliferative
capacity and responsiveness to the environment) of each partic-
ular cell type.
As discussed above, the basic concept of epigenetics is that
maintenance of chromatin marks across mitosis occurs autono-
mously and in an unsupervised manner. From a molecular point
of view, this is a well-proven concept. The classical type of
autonomous transmission of epigenetic marks from mother to
daughter chromatin fibers is that of DNA methylation, which
requires the activity of a maintenance DNA methyltransferase
(Dnmt1) as well as of two other enzymes (Dnmt3a and Dnmt3b)
that were erroneously considered to be selectively involved in
de novo DNA methylation (Klose and Bird, 2006). Dnmt1 local-izes at replication foci in mid-to-late S phase: this location
enables Dnmt1 to methylate the newly synthesized DNA mole-
cules at the same CpG dinucleotides that were methylated on
the parental strand. This mechanism is essential for the imme-
diate restoration of the original methylation profile and for main-
taining the genome methylated. However, the accuracy of DNA
remethylation is not as high as it would be required to prevent
a progressive deterioration of the DNA methylation landscape
after consecutive mitoses. In fact, it is estimated that Dnmt1
makes one remethylation error every 25 methylated sites (Laird
et al., 2004). Therefore, although Dnmt1 is absolutely required
for an efficient propagation and maintenance of DNA methyla-
tion, it does not suffice to accurately reproduce the pre-existing
epigenome (Figure 3). This clearly requires that mechanisms for
autonomousmaintenance of chromatinmarks be integratedwith
some form of supervision, so as to accurately restore their orig-
inal distribution whenever this is needed. The obvious candi-
dates for such constant supervision are those TFs that are
required to maintain the differentiated state (see below and
Figure 3).
Maintaining Histone Methylation Patterns
The only histone modification definitively demonstrated to
be capable of autonomous propagation across mitosis is
H3K27me3 (Figure 3). This modification, which brings about
transcriptional repression, is deposited by the PRC2 com-
plex (Polycomb Repressive Complex 2), which includes the
methyl-transferase Ezh2 and ancillary subunits without enzy-
matic activity (Schuettengruber et al., 2007). One such subunit,
Eed, contains a carboxy-terminal domain that directly binds
H3K27me3 and allosterically activates Ezh2 (Margueron et al.,
2009). Because the PRC2 complex localizes at replication foci
throughout S phase (Hansen et al., 2008), direct H3K27me3
recognition on the nucleosomes located on the parental strand
ensures its redeposition on the daughter strand and ultimately
its propagation across mitosis. Although the fidelity of such
mechanism is unclear, absence of Eed leads to a global reduc-
tion in H3K27me3 amounts, indicating its requirement for main-
tenance of the epigenome. Importantly, this mechanism also
guarantees that sites of H3K27me3 aremaintained in interphase,
because it keeps the PRC2 complex stably associated with
H3K27me3 sites.
In the case of H3K4me3, autonomous propagation of the
mark seems to depend on a mechanism different from those
described above (Thomson et al., 2010). Recent data point to
a direct, instructive role of the underlying DNA sequence in
the deposition of H3K4me3 at CpG islands, namely sequence
stretches enriched in unmethylated CpG dinucleotides, located
at the promoters of a large fraction of human genes, and asso-
ciated with either constitutive or rapidly inducible gene activity
(Ramirez-Carrozzi et al., 2009). This mechanism consists of
direct recognition of unmethylated CpG clusters by the CXXC-
type zinc finger of Cfp1 (Voo et al., 2000), which is a component
of the H3K4 methyltransferases (Setd1a and Setd1b) respon-
sible for the bulk of H3K4 trimethylation in mammalian cells
(Lee and Skalnik, 2005, 2008). In this case, the mark is main-
tained autonomously not because of dedicated mechanisms
of propagation, but simply because the newly synthesized
DNA strand will directly instruct the recruitment of H3K4Immunity 33, July 23, 2010 ª2010 Elsevier Inc. 17
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Figure 3. Autonomous versus Supervised Maintenance of Epigenetic Marks
Some chromatin marks can be autonomously transmitted to daughter cells, whereas others may require constant supervision by lineage-determining TFs
whose continuous presence is required to preserve cell identity. Even for those marks equipped with mechanisms of propagation across mitosis (e.g.,
DNA methylation), inaccuracy in transmission imposes the requirement for supervised mechanisms of epigenome maintenance (represented by the dashed
green line).
Immunity
Reviewmethyltransferases to CpG islands. Moreover, CpG islands
contain CG stretches that are directly recognized by the
transcription factor SP-1, which contributes to the deposition
of the H3K4me3 chromatin mark by promoting Pol_II recruit-
ment (Hargreaves et al., 2009). The functional impact of the
direct link between sequence determinants and chromatin orga-
nization was also shown for inducible gene expression in macro-
phages (Ramirez-Carrozzi et al., 2009; Smale, 2010). Specifi-
cally, the presence of a CpG island at the promoters of
inflammatory genes induced by microbial stimuli or cytokines,
correlated with a comparatively lower nucleosomal density
and the lack of requirement for nucleosome remodeling for
gene activation. This is because CG-rich sequence stretches
disfavor the formation of stable nucleosomes and therefore
create a chromatin configuration that is highly permissive for
rapid and efficient gene activation (Ramirez-Carrozzi et al.,
2009). Therefore, CpG islands are sufficient to generate two
important organizational features of chromatin at promoters:
an overall low level of nucleosomal occupancy and a promoter-
or TSS-specific histone modification (whose precise functional
impact remains to be defined).
All these data provide evidence that at least some compo-
nents of epigenomes can be autonomously maintained in spite
of mitoses and environmental perturbations. However, they
don’t address the truly outstanding question: whether these
biochemical mechanisms are ‘‘sufficient’’ to maintain the mem-
ory of the state of gene activity and, ultimately, the gene expres-
sion program characteristic of a differentiated cell. Experimental
evidence in Drosophila supports the concept that, at least in
some cases, genesmay retain their activity state in an apparently
autonomous manner through epigenetic mechanisms. Cavalli
andParo used flieswith a reporter transgene regulated by a yeast
TF (GAL4) expressed in an inducible manner from a second18 Immunity 33, July 23, 2010 ª2010 Elsevier Inc.transgene: a single burst of GAL4 switched on the reporter,
which remained hyperacetylated and active across mitoses
even after GAL4 withdrawal (Cavalli and Paro, 1999). Although
these experiments established the proof of principle that some
genes may retain a memory of their activity, they do not clarify
whether this is a widespread occurrence in differentiated cells
of complex organisms.
Overall, although the existence of well-defined molecular
mechanisms for the propagation of epigenetic marks to daugh-
ter cells is unquestionable, reasonable doubts can be cast on the
idea that these mechanisms warrant the faithful maintenance of
the original epigenome. In this context, knowledge on the func-
tional properties of some lineage-determining TFs of the immune
system is extremely informative and strongly points, as dis-
cussed below, to the general concept that the maintenance of
the epigenome and the gene expression program characteristic
of differentiated cells may indeed, in most or all cases, require
constant supervision by lineage commitment and identity factors
(Figure 3).
Loss of the Differentiated State upon Removal
of Lineage Commitment and Identity Factors
The role of Pax5 in the control of B cell differentiation and identity
provides some important concepts in this area. Pax5 is a paired-
box TF specifically expressed in the hematopoietic system
(Cobaleda et al., 2007b). In the absence of Pax5, adult B lympho-
poiesis is blocked and specifically arrested at the pro-B cell
stage. Pax5/ pro-B cells have shown very interesting proper-
ties, including the ability to differentiate towardmost other hema-
topoietic lineages when exposed to the appropriate cytokine
milieu in vitro; to reconstitute these lineages upon transplanta-
tion into recipient mice; and to reconstitute a functional T cell
compartment in RAG2-deficient mice (Nutt et al., 1999; Rolink
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lineage choice toward B lymphopoiesis, which was controlled
by TFs involved in early B cell differentiation (E2A and EBF),
they were not locked in the B cell lineage. Because we do not
have a comparative epigenomic analysis of wild-type versus
Pax5/ pro-B cells, the epigenomic counterpart of this develop-
mental plasticity is unknown. It is clear, however, that the epige-
nome of Pax5/ pro-B cells must possess some form of fluidity
that allows its conversion to alternative epigenomes in the pres-
ence of suitable environmental conditions (cytokine milieu).
Conversely, the epigenome of normal pro-B cells appears to
be ‘‘frozen’’ in the presence of Pax5. Nevertheless, upon
enforced expression of C/EBP family TFs, B cells can be reprog-
rammed into macrophages (Xie et al., 2004).
Additional important clues came from the behavior ofmature B
cells. Deletion of Pax5 in mature B cells allowed their in vivo
dedifferentiation to uncommitted progenitors with a full capacity
to reconstitute T lymphopoiesis when transferred into Rag2/
mice (Cobaleda et al., 2007a). Therefore, maintenance of mature
B cell identity requires Pax5, thus fully justifying its definition as
a lineage identity factor. In this context, developmental plasticity
may be considered as a reflection of the loss of the supervision
Pax5 exerts over the epigenome of B cells. This is clearly at odds
with the epigenetic principle that the autonomous propagation of
an established epigenome should suffice to maintain the differ-
entiated state, and is conversely compatible with the model,
discussed below, that the maintenance of the epigenome of
differentiated cells is an active process requiring constant
enforcement by the transcriptional regulator(s) defining cell iden-
tity. Pax5 directly induces an active chromatin state at genes
involved in multiple aspects of B cell function (Schebesta et al.,
2007). This is clearly sufficient to explain its role in determining
B cell differentiation and identity, but not necessarily sufficient
to explain why in its absence mature B cells can switch to alter-
native lineages. A detailed genomic profile of Pax5 occupancy is
not yet known; therefore, it is not possible to elaborate on the
precise molecular mechanisms that are responsible for prevent-
ing lineage switch. However, by analogy with PU.1 (Ghisletti
et al., 2010), it can be hypothesized that this activity of Pax5
entails a pervasive association with regulatory genomic ele-
ments (enhancers and promoters or TSS) whose activation
establishes the B cell-specific epigenome and gene expression
program, and ultimately B cell identity. When Pax5 is removed
from mature B cells, autonomous propagation of epigenetic
marks may prevent the abrupt loss of B cell identity but it will
not be sufficient to block lineage switch when suitable conditions
(including active proliferation) ensue.
A situation where autonomous epigenetic mechanisms may
conversely suffice to prevent a cell fate switch is the differentia-
tion of CD8+ T lymphocytes. In T cells committed to the CD8+
lineage, the Cd4 gene is permanently repressed through an
intronic silencer element. In fully committed CD8+ T cells, this
silencer can be removed without compromising Cd4 gene
silencing, indicating that the repressed state can be permanently
maintained in an autonomous manner (Zou et al., 2001).
Pax5 displays some analogies, but many important differ-
ences, with Foxp3, a forkhead box TF controlling the develop-
ment of a highly specialized CD4+ T cell subset: regulatory T
(Treg) cells (Lu and Rudensky, 2009). In the absence of Foxp3,Treg cells cannot be generated. Importantly, removal of Foxp3
from mature Treg cells resulted in the loss of their specific
gene expression program (Williams and Rudensky, 2007). In
response to stimulation, Treg cells in which Foxp3 was removed
expressed cytokines that are not produced by normal Treg cells
including interleukin 2 (IL-2) and cytokines characteristic of
different types of CD4+ T cells, and particularly T helper 1 (Th1)
cells, like interferon-gamma (IFN-g) and tumor necrosis factor
alpha (TNF-a). What is most striking is the efficiency of this
reprogramming, with about 40% of the stimulated Foxp3-
deleted Treg cells expressing cytokines that do not belong to
this lineage (Williams and Rudensky, 2007). This implies that
reprogramming is not at all a random, stochastic event, but
almost an obligate consequence of Foxp3 loss. More generally,
the whole transcriptional program characteristic of Treg cells
was disabled upon loss of Foxp3. Nevertheless, there is no
reported evidence that these cells can become something else
other than types of T lymphocytes: loss of identity is somehow
partial. This is simply because Foxp3 has a comparatively
narrow function in T cell differentiation, which consists in redi-
recting differentiation toward specific functional prerogatives.
This is in keeping with the genomic distribution of Foxp3, which
is limited to less than 1500 sites corresponding to about 700
genes that are differentially expressed in Treg cells (Zheng
et al., 2007). When compared to the 45,000 genomic sites bound
by PU.1 in macrophages (Ghisletti et al., 2010), it is clear that the
impact of these two factors on their respective genomes ismark-
edly different.
Therefore, there seems to be a hierarchy among lineage
commitment and identity factors, with some of them (like PU.1
and maybe Pax5) being able to pervasively shape the genomic
landscape, cause major developmental decisions, and maintain
lineage identity; whereas others (like Foxp3) are involved in acti-
vation of highly specialized gene expression programs within
a general organizational and differentiation plan defined by TFs
at a higher hierarchical level.
Lineage-Commitment and Identity Factors as Global
Genomic Organizers
There is a classic idea that developmental biologists grew up
with: TFs controlling cell differentiation simply activate the
expression of lineage-specific genes and, if necessary, repress
the activation of lineage-inappropriate genes (Figure 4). There-
fore, their competence may be restricted to a handful of genes
that are crucial to define cell identity. Genes that are not lineage
restricted are by definition housekeeping and they are supposed
to be entirely controlled by TFs expressed across cell types
without any supervision exerted by cell type-specific TFs.
What we know today is that, in addition to expressing a rela-
tively small number of lineage-specific genes, every cell type
possesses an epigenome whose active regions and regulatory
elements differ extensively from those of other cell types in the
organism (Figure 1). In the specific case of the genomic regions
with signature and function of enhancers, the overlap among
different cell types appears to be rather small (Heintzman
et al., 2009; Heinz et al., 2010), although other functional cis-
regulatory elements, like the insulators bound by CTCF, are rela-
tively cell type invariant (Kim et al., 2007; Cuddapah et al., 2009).
Moreover, fine-scale selection of the site(s) where transcriptionImmunity 33, July 23, 2010 ª2010 Elsevier Inc. 19
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Figure 4. A Model of Global Genomic Organization Supervised by
Lineage Determining TFs
In the classic model of cell differentiation (left), cell fate-determining TFs have
a limited role consisting in the activation of lineage-specific genes coupled
with the repression of lineage-inappropriate genes. However, several pieces
of experimental evidence point to the concept that lineage commitment and
identity factors may have a pervasive role in controlling the behavior of differ-
entiated cells (right), supervising in a constant manner the functional organiza-
tion of the genome.
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specific signals (Carninci et al., 2006; Kawaji et al., 2006).
This emerging picture is dramatically different from that
coming from classic developmental models. Specifically, we
are shifting from a model in which only a few regulatory events
(activation of lineage-specific genes) are directly controlled by
lineage commitment and identity factors, to a model in which
a large number of, and possibly nearly all, regulatory events
(including function of enhancers and transcriptional initiation) in
the nucleus are actively supervised. The data on the genomic
distribution of PU.1 in macrophages offer a simple explanation
of how a global supervision over transcriptional regulation and
cell identity can be achieved at the molecular level (Ghisletti
et al., 2010; Heinz et al., 2010). PU.1 marks the vast majority of
the genomic regions with a chromatin signature of enhancers,
and about 80% of the promoters and TSSs associated with
active genes. Moreover, it appears to have a direct role in acti-
vating the genomic regions it binds into functional enhancers,
thus directly creating the genomic regulatory landscape (i.e.,
the epigenome) (Ghisletti et al., 2010; Heinz et al., 2010). Simul-
taneous marking of enhancers and promoters also suggests the
possibility that homotypic interactions between enhancer-
bound and promoter- or TSS-bound PU.1 molecules may be
instrumental to the creation of a three-dimensional network of
interactions that are necessary to bring into proximity distant
regulatory elements. This idea is supported by evidence in B
cells, in which the long-range interaction between a distal hyper-20 Immunity 33, July 23, 2010 ª2010 Elsevier Inc.sensitive site and aB cell-specific promoter that controls expres-
sion of the class II transactivator (CIITA) was shown to require
PU.1 (Yoon and Boss, 2010). Overall, these data suggest that
the epigenome characteristic of a differentiated cell type (orga-
nized along the 1-dimensional genome and in the 3D space)
may be explained, at least to a large extent, by the activity of
a single TF. Therefore, from an operational andmechanistic point
of view, lineage commitment and identity factors act as ‘‘global
genomic organizers’’ (Figure 4). Additional lineage-restricted
TFs collaborate, at a lower hierarchical level, with one or a few
global genomic organizers to bind and activate subsets of
enhancers. For instance, in B cells, in which expression of
PU.1 is several times lower than in macrophages, TFs like E2A
and EBF are required to direct PU.1 to large subsets of genomic
sites (Heinz et al., 2010). However, such a strong reliance on
partner TFs for binding to many genomic sites is alleviated at
higher PU.1 concentrations: when nuclear concentrations of
PU.1 similar to those of macrophages were achieved by retro-
viral transduction of fibroblasts, more than 85% of macrophage
binding sites were recapitulated in a genome-wide analysis (our
unpublished results). Nevertheless, even in these conditions of
enforced expression, some genomic regions (that were enriched
for binding sites for macrophage-specific TFs) were not bound
by PU.1, suggesting the requirement for macrophage-restricted
partners. These data confirm the notion that combinatorial inter-
actions between lineage-restricted TFs may be required for
binding of master regulators like PU.1 to a subset of genomic
targets; and that overall reliance on partner TFs may depend
on the concentration of a given lineage commitment and identity
TF (Heinz et al., 2010). Because of such a high dependence on
partner TFs when its concentration is low, genomic distribution
of PU.1 is dramatically different in macrophages and B cells,
particularly at promoter-distal sites (Heinz et al., 2010), thus
leading to a completely different enhancer repertoire in these
two cell types.
According to this working hypothesis, a global genomic orga-
nizer is a TF with a few essential prerogatives (Figure 4): (1)
pervasive, global occupancy of the active regulatory regions of
the genome; (2) ability to activate and maintain as enhancers
the genomic regions it binds to; (3) systematic binding near
TSSs; (4) involvement in promoter-enhancer 3D interactions;
and (5) absolute requirement for its continuous presence for
the maintenance of the epigenome and the gene expression
program specific of the differentiated cell. It is therefore implicit
in this model that maintenance of the specific epigenome and
the gene expression program characteristic of a differentiated
cell type requires continuous and systematic enforcement in
addition to general epigenetic mechanisms for propagation of
chromatin marks across mitosis (Figure 3). Therefore, in agree-
ment with the experimental data discussed above, this model
argues against the notion that the epigenome is established
during differentiation by a transient activity of one or more
lineage-determining TFs and then autonomously maintained.
An inference of the model is that also the 3-dimensional orga-
nization of the genomewill be actively shaped by global genomic
organizers and therefore, to a certain extent, will be different
among cell types. Although 3D genomic landscapes are only
beginning to be unraveled (Lieberman-Aiden et al., 2009),
some data support this possibility. Indeed, interchromosomal
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be cell type specific (Spilianakis et al., 2005).
Dynamic changes in gene expression such as those induced
by external stimuli occur within the genomic landscape directly
created by global genomic organizers (Ghisletti et al., 2010).
For instance, stimulus-inducible TFs in macrophages preferen-
tially land at the genomic regions premarked and activated by
PU.1, and binding will not occur in its absence (Heinz et al.,
2010). Because each cell type has a unique genomic landscape,
created by its own specific global genomic organizer(s), this
provides a molecular explanation for the well-known impact of
the cellular context on responses to identical stimuli.
FromGlobalGenomicOrganization toCell Type-Specific
Gene Expression
This systematic and constant control exerted by such putative
global genomic organizers may seem overkill for the needs of
differentiated cells. Specifically, how many genes have to be
switched on and off by a lineage commitment factor to make
a differentiated cell? And how do such widespread genomic
distributions relate to gene expression changes caused by
commitment and identity factors? Overall, genomic binding
events seem to greatly exceed the number of genes that are
directly regulated by lineage determining and identity factors
(see Cao et al., 2010, for an exemplary analysis). At a first glance,
this may be interpreted as evidence that most binding events are
nonfunctional. However, at this stage this conclusion would be
rather superficial, as it is basedonbotharbitrarily selected thresh-
olds for gene expression changes and on the assumption that
in vitro cultured cells (where experiments of this kind are routinely
carried out) will behave similarly to cells in their natural environ-
ment. This is clearly a major issue, because enhancers (where
commitment and identity factors preferentially bind) have a formi-
dable specificity in their activity, which cannot be recapitulated in
a Petri dish. For instance, the three enhancers controlling Foxp3
expression are differentially used by Treg cells in the thymus
and in peripheral lymphoid tissues, as could be clarified by their
individual deletion in mutant mice (Zheng et al., 2010). Therefore,
at this stage we can safely conclude that we do not know exactly
what is the functional impact of each of themany thousands of TF
binding event detected in the genome via high-throughput
sequencing technologies; and that the available knowledge is
fully compatible with the notion that many more binding events
may have functional consequences than can be extrapolated
by cDNA microarray data. A second issue is why differentiated
cells should care about regulation of ‘‘housekeeping genes.’’
A simple key may be that although broadly expressed, the so-
called housekeeping genesmay have to be fine-tuned according
to the need of every specific cell type, which would impose the
convergence on their regulatory regions of those transcription
factors thatmaintain cell identity, or themodificationof their chro-
matin environment so as to promote different levels of gene
activity. Evidence supporting this notion is the fact the mRNA
levels of housekeeping genes dynamically change during cell
reprogramming (E. Kallin and T. Graf, personal communication).
A Glimpse outside of the Hematopoietic System
One important aspect is that although this model is based on
data obtained in cells of the immune system, what is known inother systems is fully compatible with it. The most obvious
example is that of MyoD, a TF controlling muscle development.
In what was probably the first cell reprogramming experiment
achieved with isolated genes, it was shown that expression of
MyoD in fibroblasts is sufficient to convert them into muscular
cells (Davis et al., 1987). However, the reprogrammed state is
labile until endogenous MyoD is permanently turned on. There-
fore, also in this case the stability of the differentiated state
requires constant enforcement by a commitment and identity
factor. Interestingly, MyoD has been recently shown to mark
about 60,000 genomic sites, including the promoters of muscle-
specific genes, and inter- or intragenic regions that may repre-
sent enhancers (Cao et al., 2010). Although gene expression
changes occurring during differentiation from myoblasts to
myotubes are of comparatively small amplitude (affecting 4%
of the genes), MyoD is sufficient to increase histone acetylation
at most of the thousands of genomic regions it binds. This
suggests that the widespread deposition of chromatin alter-
ations may represent an intrinsic component of MyoD activity
that contributes, together with the activation of muscle-specific
genes, to the induction and maintenance of the differentiated
state.
Another example comes from GATA3. In addition to being
required for differentiation of Th2 cells, GATA3 is highly
expressed in mammary epithelium: its acute loss was shown
to lead to the expansion of a population of cells lacking differen-
tiation markers and to a major alteration of tissue organization
(Kouros-Mehr et al., 2006).
I would like to conclude with the idea that the need for a global
and constant supervision for a correct functioning of a complex
machine is something that was invented at least twice: in evolu-
tion, to guarantee the maintenance of identity in differentiated
cells of complex organisms; and by engineers who invented
computers. Computer processor units (CPU) are made of
millions of transistors organized in modules, each module with
specific and dedicated functions. In spite of the complexity of
the system, any module in the CPU can work only when it
receives a signal from the master clock (which oscillates at a
frequency indicated in GHz). At every signal (oscillation) of the
master clock the components of the CPU can work, otherwise
all activities are blocked. This way it is guaranteed that all events
are coordinated. Although TFs maintaining cell identity clearly
work in a nonoscillatory fashion, this analogy shows that a global
supervision exerted by a single regulator is compatible with the
efficient functioning of very complex machines.ACKNOWLEDGMENTS
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